Eqis Capital Management »

Immunitybio shares owned by Eqis Capital Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Eqis Capital Management from 13F filings

Historical chart of Eqis Capital Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Eqis Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Eqis Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $54k 10k 5.37
2023-09-30 $19k 11k 1.69

More positions owned by Eqis Capital Management

Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Us High Profitab (DUHP)
Vanguard Index Fds Value Etf (VTV)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (FJAN)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Vlu Ft (IVLU)
Wisdomtree Tr Us Midcap Fund (EZM)
Kraneshares Trust Kraneshares Valu (KVLE)
Pimco Etf Tr Active Bd Etf (BOND)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Ishares Tr Core Msci Eafe (IEFA)
Wisdomtree Tr Intl Smcap Div (DLS)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Eqis Capital Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
Geode Capital Management
Susquehanna International
Credit Suisse
Jpmorgan Chase & Co
Northern Trust
Rafferty Asset Management
Bank of America Corporation
Goldman Sachs Group
Charles Schwab Investment Management
Citigroup
Perceptive Advisors
Citadel Advisors
Sheets Smith Wealth Management

View all funds holding Immunitybio